Koers Bellicum Pharmaceuticals, Inc. OTC Markets
Aandelen
BLCM
US0794814048
Biotechnologie & Medisch Onderzoek
Omzet 2021 | 6,2 mln. 5,82 mln. | Omzet 2022 | 1,5 mln. 1,41 mln. | Marktkapitalisatie | 822K 771K |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -9 mln. -8,45 mln. | Nettowinst (verlies) 2022 | -25 mln. -23,46 mln. | EV/omzet 2021 * | - |
Nettoliquiditeiten 2021 * | - 0 | Nettoliquiditeiten 2022 * | - 0 | EV/omzet 2022 * | - |
K/w-verhouding 2021 * |
-
| K/w-verhouding 2022 * |
-
| Werknemers | 13 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 * |
-
| Vrij verhandelbaar | 98,45% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,49% | 96,73 mld. | |
-0,49% | 21,31 mld. | |
-16,61% | 21,21 mld. | |
-5,29% | 18,79 mld. | |
-42,14% | 16,37 mld. | |
-27,40% | 13,68 mld. | |
+1,44% | 13,44 mld. | |
+21,29% | 10,98 mld. | |
-21,79% | 8,56 mld. |